3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
58
Recurrence
7
Neoplasms, Plasma Cell
6
Lymphoma
6
Immunoglobulin Light-chain Amyloidosis
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Paraproteinemias
2
Neoplasms
2
Lymphoma, T-Cell
2
Lymphoma, Mantle-Cell
2
Leukemia, Myeloid, Acute
2
beta-Thalassemia
1
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Thalassemia
1
Sarcoma, Myeloid
1
Renal Insufficiency
1
Prostatic Neoplasms
1
Plasmablastic Lymphoma
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Interventions
Azacitidine
12
Cyclophosphamide
10
venetoclax
8
fludarabine phosphate
7
fludarabine
7
Whole-Body Irradiation
7
Biopsy
7
Specimen Handling
6
Mycophenolic Acid
6
Injections
6
Decitabine
6
Tacrolimus
5
Cytarabine
5
Busulfan
5
decitabine and cedazuridine drug combination
4
Stem Cell Transplantation
4
Peripheral Blood Stem Cell Transplantation
4
Cyclosporine
4
cedazuridine
3
X-Rays
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
olutasidenib
2
Vorinostat
2
Sirolimus
2
Rituximab
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Lenalidomide
2
Idarubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Chronic
×
Bortezomib
×
90 days
×
Clear all
No trials found.